...
首页> 外文期刊>Journal of research in medical sciences : >EFFECT OF TETANUS-DIPHTHERIA (TD) VACCINE ON IMMUNE RESPONSE TO HEPATITIS B VACCINE IN HEALTHY INDIVIDUALS WITH INSUFFICIENT IMMUNE RESPONSE
【24h】

EFFECT OF TETANUS-DIPHTHERIA (TD) VACCINE ON IMMUNE RESPONSE TO HEPATITIS B VACCINE IN HEALTHY INDIVIDUALS WITH INSUFFICIENT IMMUNE RESPONSE

机译:破伤风-破伤风(TD)疫苗对免疫应答不足的健康个体对乙型肝炎疫苗的免疫反应的影响

获取原文
           

摘要

Background: Hepatitis B virus (HBV) fails to produce appropriate immune responses in some healthy individuals; thus, different strategies have been adopted to promote immune responses. The current study aimed at evaluating the efficacy of HBV vaccine coadministered with tetanus-diphtheria (Td) vaccine compared with HBV vaccine in healthy individuals through measuring hepatitis B surface antibody (HBsAb) levels. Materials and Methods: This was a randomized controlled clinical trial, which was implemented in Isfahan, Isfahan Province (Iran) in 2013. One hundred and forty healthy individuals, whose HBsAb titers were less than 10 IU/L were recruited. The subjects were randomly assigned to either in intervention or control trials. The control group received 40 ?g of recombinant HBV vaccines intramuscularly injected at 0, 1, and 6 months; however, the intervention group was simultaneously vaccinated by Td with the first dose of HBV vaccine. HBV antibody levels (titer) were measured before the vaccination and 6 months after the last vaccination.Results: Antibody titers of the subjects in the intervention and control groups increased from 5.07 ± 2.9 IU/L to 744.45 ± 353.07 IU/L and from 4.45 ± 3.4 IU/L to 589.94 ± 353 IU/L, respectively (both P Conclusion: Td vaccination can be applied as a feasible approach to promote efficient and persistent immunity in healthy individuals with insufficient HBsAb titers.
机译:背景:乙型肝炎病毒(HBV)无法在某些健康个体中产生适当的免疫反应。因此,已经采用了不同的策略来促进免疫反应。当前的研究旨在通过测量乙型肝炎表面抗体(HBsAb)水平,评估与破伤风-白喉(Td)疫苗联合使用的HBV疫苗与HBV疫苗在健康个体中的疗效。材料与方法:这是一项随机对照临床试验,于2013年在伊斯法罕省(伊朗)的伊斯法罕实施。招募了HBsAb滴度低于10 IU / L的140例健康个体。将受试者随机分为干预试验或对照试验。对照组分别在0、1、6个月时肌肉注射40μg重组HBV疫苗。但是,干预组同时接种了第一剂乙肝疫苗的Td疫苗。结果:干预组和对照组受试者的抗体滴度从5.07±2.9 IU / L增加到744.45±353.07 IU / L和4.45,从接种前和接种后6个月开始测量。分别为±3.4 IU / L至589.94±353 IU / L(均P结论:Td疫苗接种可作为在HBsAb滴度不足的健康个体中提高有效和持久免疫力的可行方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号